| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/1994 | WO1994004142A1 Novel metallocenes as anti-tumor drugs |
| 03/03/1994 | WO1994004141A1 π-BOND AROMATIC VITAMIN CHELATES |
| 03/03/1994 | WO1994004140A1 Antiprotozoan drug |
| 03/03/1994 | WO1994004139A1 Treatment of human viral infections |
| 03/03/1994 | WO1994004138A1 Sustained release tablets containing bupropion |
| 03/03/1994 | WO1994004136A1 Method for treatment and prevention of irritable bowel syndrome and pharmaceutical compositions therefor |
| 03/03/1994 | WO1994004134A1 Ophthalmological preparation |
| 03/03/1994 | WO1994004133A1 Inhalation powder containing antistatic agent |
| 03/03/1994 | WO1994004129A2 Cosmetic and dermatological sunscreen compositions containing thiols and/or thiol derivates |
| 03/03/1994 | WO1994004128A2 Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions |
| 03/03/1994 | WO1994004122A2 Use of diacylglycerols for increasing the melanin content in melanocytes |
| 03/03/1994 | WO1994004120A2 Methods of treating sexual dysfunction in animals with and h agonist |
| 03/03/1994 | WO1994004109A1 Printed transdermal drug delivery device |
| 03/03/1994 | WO1994004017A2 New method of treatment |
| 03/03/1994 | WO1993023035A3 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease |
| 03/03/1994 | WO1993023021A3 Therapeutic combinations |
| 03/03/1994 | WO1993015205A3 Synthetic haemophilus influenzae conjugate vaccine |
| 03/03/1994 | DE4328329A1 Freeze-dried polysaccharide bio-matrix useful as pharmaceutical or cosmetic carrier - comprises mixt. of natural and modified material e.g. pectin, alginate, agar, cellulose ether deriv. etc. |
| 03/03/1994 | DE4305881C1 Transdermal therapeutic system for topical and systemic application of active agents - includes cpd(s) from which nitrogen oxide is released by human or animal metabolism or cpds which release nitrogen oxide in organism |
| 03/03/1994 | DE4229230A1 Transdermales therapeutisches System mit Pentylentetrazol als Wirkstoff Transdermal therapeutic system with pentylenetetrazole as active ingredient |
| 03/03/1994 | DE4229166A1 Mittel zur Aufrechterhaltung und/oder Steigerung der Muskelleistung und Körperzellmasse Means for maintaining and / or increasing muscle performance and body cell mass |
| 03/03/1994 | DE4229053A1 Pharmaceutical prepns. for promotion of skin circulation - contg. 9-chloro-prostaglandin derivs. |
| 03/03/1994 | DE4229051A1 Pharmaceutical prepns. for treatment of elevated intraocular pressure - contg. 9-chloro-prostaglandin derivs. |
| 03/03/1994 | DE4229050A1 New esters and amides of 9-chloro-prostaglandins - useful, e.g., in treatment of glaucoma and as diuretic agents |
| 03/03/1994 | DE4229048A1 New ester(s) of 9-chloro-prostaglandin(s) - useful in treatment of glaucoma and as diuretic agents |
| 03/03/1994 | DE4228926A1 Spritzfertige Azosemid-Injektionslösungen Spray Ready azosemide injection solutions |
| 03/03/1994 | DE4228552A1 Diphosphonsäuren und deren Salze enthaltende Arzneimittel Diphosphonic acids and their salts, pharmaceutical compositions containing them |
| 03/03/1994 | DE4228215A1 Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen Use of ribose for the preparation of a medicament for the treatment of poor performance of the body, in particular of organ insufficiency |
| 03/03/1994 | DE4228106A1 Tumour diagnosis and treatment in organs, esp. urinary system - comprises admin. of gamma-amino-levulinic acid as photosensitiser, detection, and treatment by irradiation with neodymium-yttrium-aluminium-garnet laser |
| 03/03/1994 | CA2143336A1 Tissue specific transcriptional regulatory element |
| 03/03/1994 | CA2143306A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 03/03/1994 | CA2143003A1 Use of diacylolycerols for increasing the melanin content in melanocytes |
| 03/03/1994 | CA2142881A1 Detection and therapy of lesions with biotin/avidin conjugates |
| 03/03/1994 | CA2142875A1 The use of h2 and h3 agonists to treat sexual dysfunction |
| 03/03/1994 | CA2142871A1 Printed transdermal drug delivery device |
| 03/03/1994 | CA2142863A1 Homeopatic compositions for the treatment of viral and metabolic diseases |
| 03/03/1994 | CA2142831A1 Treatment of human viral infections |
| 03/03/1994 | CA2142826A1 Crosslinked polymeric ammonium salts |
| 03/03/1994 | CA2142817A1 Ophthalmological preparation |
| 03/03/1994 | CA2142721A1 Condensed indole derivatives as 5ht and 5ht antagonists |
| 03/03/1994 | CA2142711A1 Method for destroying or inhibiting growth of unwanted cells or tissues |
| 03/03/1994 | CA2142313A1 Use of inhibitors of vacuolar-type h atpases |
| 03/03/1994 | CA2142305A1 Opioid receptor genes |
| 03/03/1994 | CA2142295A1 Methods useful in endotoxin prophylaxis and therapy |
| 03/03/1994 | CA2142288A1 27-hydroxyrapamycin and derivatives thereof |
| 03/03/1994 | CA2142270A1 Astragalus polysaccharide immunomodulators |
| 03/03/1994 | CA2142223A1 Methods of treating psoriasis employing substituted azaspiranes |
| 03/03/1994 | CA2142110A1 Antiangiogenic oligomers |
| 03/03/1994 | CA2142016A1 Method for treatment and prevention of irritable bowel syndrome and pharmaceutical compositions therefor |
| 03/03/1994 | CA2141939A1 Pharmaceutically active diketopiperazines |
| 03/03/1994 | CA2141938A1 Pharmaceutically active diketopiperazines |
| 03/03/1994 | CA2141690A1 Transdermal application agent containing 3-keto-desogestrel |
| 03/03/1994 | CA2140865A1 Antiproliferative oligomers |
| 03/03/1994 | CA2140653A1 Protein kinase inhibitors and related compounds combined with taxol |
| 03/03/1994 | CA2140640A1 Tachykinin antagonists |
| 03/03/1994 | CA2139946A1 Method for treating cardiovascular disease through adjunctive photodynamic therapy |
| 03/03/1994 | CA2138521A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 03/03/1994 | CA2138518A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/03/1994 | CA2136842A1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors |
| 03/03/1994 | CA2136838A1 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/03/1994 | CA2120916A1 Benzoheterocyclic compounds |
| 03/03/1994 | CA2120726A1 Androst-4-eno¬4,5-b|pyrrole derivatives and process for their preparation |
| 03/03/1994 | CA2105345A1 Chemical compound |
| 03/03/1994 | CA2104895A1 Inhibitor of herpes simplex viral thymidine kinase |
| 03/03/1994 | CA2104267A1 3-oxadiazolyl-1,6-naphthyridine derivatives |
| 03/02/1994 | EP0585206A1 Tryptamines for treatment of circadian rhythm disorders |
| 03/02/1994 | EP0585170A1 Composition for treating acne which contains at least one derivative of salicyclic acid |
| 03/02/1994 | EP0585116A1 1-Alkoxy-naphthalene-2-carboxamide derivatives with high affinity for the serotonin 5-HT1A receptor |
| 03/02/1994 | EP0585080A2 Oxygenated heterocyclic compounds, pharmaceutical compositions containing them |
| 03/02/1994 | EP0585067A1 Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis |
| 03/02/1994 | EP0585058A1 Pharmaceutical compositions containing fatty acids and heparin |
| 03/02/1994 | EP0585057A1 Lithium salts of fatty acids for the treatment of viral infections and cancer |
| 03/02/1994 | EP0585027A1 Use of fatty acids for treating abnormal tissue calcification |
| 03/02/1994 | EP0585026A1 Use of fatty acids for increasing gut calcium absorption |
| 03/02/1994 | EP0584952A1 Improvements in or relating to benzothiophenes |
| 03/02/1994 | EP0584903A1 Process for preparing aryl piperazinyl-heterocyclic compounds |
| 03/02/1994 | EP0584797A2 Novel cephalosporin compounds and processes for the preparation thereof |
| 03/02/1994 | EP0584694A1 Imidazolidin derivatives |
| 03/02/1994 | EP0584588A1 Anti-ulcer composition containing imidazole derivative |
| 03/02/1994 | EP0584552A2 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 03/02/1994 | EP0584535A1 Use of oxatomide as antitussive agent |
| 03/02/1994 | EP0584487A2 4,5-Dihydro-4-oxopyrrolo (1,2-a) quinoxalines and aza-analoges and process for their preparation |
| 03/02/1994 | EP0584461A1 5-Haloimidazoles |
| 03/02/1994 | EP0584347A1 Enantiomeric hydroxylated xanthine compounds |
| 03/02/1994 | EP0584340A1 Diagnosis and treatment of various neuralgias |
| 03/02/1994 | EP0584339A1 Method of delivering therapeutic substances to the brain |
| 03/02/1994 | EP0584285A1 Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 03/02/1994 | EP0584250A1 Novel composition of angiotensin-ii receptor antagonists and calcium channel blockers |
| 03/02/1994 | EP0584223A1 Novel immunosuppressive compounds |
| 03/02/1994 | EP0584208A1 Pyrrolidinones |
| 03/02/1994 | EP0584200A1 Trifluoromethyl analogs of fucose and uses thereof |
| 03/02/1994 | EP0584192A1 Prodrug esters of phenolic 2-piperidino-1-alkanols |
| 03/02/1994 | EP0584185A1 Treatment of fatigue syndrome with cholinesterase inhibitors |
| 03/02/1994 | EP0584175A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |
| 03/02/1994 | EP0584159A1 Nutrient preparation. |
| 03/02/1994 | EP0584148A1 Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent |
| 03/02/1994 | EP0584108A1 Pharmaceutical composition comprising ibuprofen salt |
| 03/02/1994 | EP0584091A1 Benzopyranones, methods of manufacture and use thereof. |
| 03/02/1994 | EP0584088A1 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers |
| 03/02/1994 | EP0584085A1 Antibiotic carbapenem derivatives |